Evidence to Innovation
-
Commonly prescribed antihistamine is linked with elevated rates of tic, anxiety, and conduct disorders in children
Hydroxyzine is a first-generation antihistamine commonly prescribed in syrup form to infants and young children with itch-inducing skin conditions, such as atopic dermatitis and eczema. New research shows that the more hydroxyzine a child is prescribed, the higher their risk for developing a tic, anxiety, or conduct disorder.
-
Congratulations CIHR Spring 2022 Project Grant recipients
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) and Women’s Health Research Institute (WHRI) investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Spring 2022 Project Grant competition. Our research community received around $15 million in new research grants as principal investigators or co-investigators.
-
Nurturing through nature – $1.3 million grant will help increase outdoor play in daycares
Outdoor time has always been a priority for Deborah Bakker and her family, and even more so during the pandemic. At the beginning of COVID-19, when her two young girls were at home full time while she and her husband were juggling work, their afternoon routine quickly moved outside. Every day, there was a two-hour…
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.
for media